Journal of Biomedical Science · 2015 · 19 citations · 40 references
Life SciencesBiotechnologyGeneticsStem Cell BiologyStem Cell BiotechnologyStem Cell TransplantationMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyStem Cell Gene TherapyStem Cell GenomicsZinc Finger NucleasesBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsGenome Editing By Homology-directed RepairHomology-directed Repair PathwayZinc Finger Nuclease EditingZinc Finger Nuclease KnockoutZinc Finger Nuclease-mediated Repair
BACKGROUNDS: Homozygous 32-bp deletion of the chemokine receptor 5 gene (CCR5) is associated with resistance to human immunodeficiency virus (HIV) infection, while heterozygosity delays HIV progression. Bone marrow transplantation (BMT) from a 32/32 donor has been shown to cure an HIV-infected patient. However, the rarity of this mutation and the safety risks associated with current BMT protocols are the major obstacles to this treatment. Zinc finger nuclease (ZFN) targeting is a powerful method for achieving genomic disruption at specific DNA sites of interest. RESULTS: Taking advantage of the self-renewal and plasticity properties of stem cells, in this study, we successfully generated isogenic and six-cell clones of bone marrow-derived mesenchymal stem cells that carry the stop codon of the CCR5 gene by using a ZFN-mediated homology-directed repair technique. These cells were expandable for more than 5 passages, and thus show potential to serve as an individual's cell factory. When Oct4 was overexpressed, the mutated cells robustly converted to CD34+ progenitor cells. CONCLUSION: We here reported the novel approach on generation of patients own CD34 cells from high fidelity ZFN-mediated HDR MSC clones. We believe that our approach will be beneficial in future HIV treatment.
40
Fibroblast precursors in normal and irradiated mouse hematopoietic organs.
Friedenstein Aj, Gorskaja Jf, Kulagina Nn · PubMed · 1976 · 1.6K citations